Celcuity Inc (CELC)
14.13
-0.50
(-3.42%)
USD |
NASDAQ |
Nov 14, 16:00
14.13
0.00 (0.00%)
After-Hours: 20:00
Celcuity Total Liabilities (Quarterly): 115.86M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 115.86M |
March 31, 2024 | 54.44M |
December 31, 2023 | 51.45M |
September 30, 2023 | 49.49M |
June 30, 2023 | 43.38M |
March 31, 2023 | 41.65M |
December 31, 2022 | 41.93M |
September 30, 2022 | 21.77M |
June 30, 2022 | 19.16M |
March 31, 2022 | 18.39M |
December 31, 2021 | 17.20M |
September 30, 2021 | 17.36M |
June 30, 2021 | 15.77M |
March 31, 2021 | 1.192M |
December 31, 2020 | 1.254M |
Date | Value |
---|---|
September 30, 2020 | 1.152M |
June 30, 2020 | 0.8401M |
March 31, 2020 | 0.8776M |
December 31, 2019 | 0.9832M |
September 30, 2019 | 1.030M |
June 30, 2019 | 1.049M |
March 31, 2019 | 1.077M |
December 31, 2018 | 0.6822M |
September 30, 2018 | 0.9819M |
June 30, 2018 | 0.9861M |
March 31, 2018 | 0.783M |
December 31, 2017 | 0.5781M |
September 30, 2017 | 0.3364M |
June 30, 2017 | 7.352M |
December 31, 2016 | 0.4454M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.8401M
Minimum
Jun 2020
115.86M
Maximum
Jun 2024
27.06M
Average
18.39M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
CEL-SCI Corp | 15.60M |
AIM ImmunoTech Inc | 9.613M |
IGC Pharma Inc | 2.714M |
NovaBay Pharmaceuticals Inc | 4.542M |
Protalix BioTherapeutics Inc | 62.96M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 292.54M |
Shareholders Equity (Quarterly) | 176.68M |